Comanagement News

An interesting case was recently discussed among the optometrists and surgeons at Pacific Cataract and Laser Institute.

The National Institutes of Health says that most diseases, except trauma-based conditions, have a genetic determinant. Keratoconus is no exception.

ATLANTA – Clinicians should evaluate choroidal nevi for five factors when deciding to refer or follow the patient, according to Steve Ferrucci, OD, FAAO, here at SECO.

Roberto “Bobby” Saenz, OD, MS, FAAO, provides an overview of his SECO presentation that focuses on “cutting edge” comanagement, including refractive, cataract and keratoconus needs.

This year's SECO meeting will be a mix of virtual presentations and live sessions that will take place in Atlanta, April 28 to May 2.

One of the strategies for severely ill patients with COVID-related acute respiratory distress is to place them in prolonged prone positioning.

Last month we explored the risk factors for a compromised capsule during cataract extraction. We will now explore different surgical options for lens implantation in the face of this complication, as well as their risks and benefits.

FDA approval of the first gene therapy in December 2017 marked the beginning of a new chapter in medical practice.

Most patients know about cataracts, but they might not fully understand what they are.

As we all know, the move from intracapsular cataract surgery, where the capsule and the lens are removed together, to extracapsular, where the capsule is left in place to secure the IOL, revolutionized cataract surgery.